Profil
Sébastien Enault is currently the Chief Business Officer at MedinCell SA since 2020.
Prior to this, he worked as the Head of Business Development at Deinove SA.
Postes actifs de Sébastien Enault
| Sociétés | Poste | Début |
|---|---|---|
| MEDINCELL S.A. | Corporate Officer/Principal | 01/11/2020 |
Anciens postes connus de Sébastien Enault
| Sociétés | Poste | Fin |
|---|---|---|
| DEINOVE | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
17
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MEDINCELL S.A. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Deinove SA
 Deinove SA BiotechnologyHealth Technology Deinove SA is a biotechnology company, which engages in the development of new-generation anti-infective antibiotics and bioactives. Its portfolio include Phy-N-Resist and HEBELYS. The company was founded by Philippe Pouletty and Miroslav Radman on October 11, 2006 and is headquartered in Grabels, France. | Health Technology |